3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
Cisplatin
7
Radiotherapy
5
S 1 (combination)
3
Paclitaxel
3
Fluorouracil
3
Capecitabine
3
toripalimab
1
tegafur-gimeracil-oteracil
1
nimotuzumab
1
nedaplatin
1
apatinib
1
Tegafur
1
TP protocol
1
Surgical Procedures, Operative
1
Radiation
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Immunotherapy
1
Fluorodeoxyglucose F18
1
Drug Therapy
1
Cetuximab
1
Carboplatin
1
CP protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Esophageal Neoplasms
×
CP protocol
×
Clear all
NCT01404156
2024-08-28
POWERRANGER
CancerCare Manitoba
Phase 2/3
Completed
29 enrolled